Asenapine treatment and health-related quality of life in patients experiencing bipolar I disorder with mixed episodes: post-hoc analyses of pivotal trials

References

• First MBFA, Pincus HA. DSM-IV-TR (Diagnostic and Statistical Manual of Mental Disorders-IV: Text Revision) Handbook of Differential Diagnosis. American Psychiatric Press Inc., 2002
   Google Scholar
• Castle DJ. Bipolar mixed states: still mixed up? Curr Opin Psychiatry 2014;27:38-42
   PubMed Web of Science ®Google Scholar
• Dilsaver SC, Chen YW, Swann AC, et al. Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res 1997;73:47-56
   PubMed Web of Science ®Google Scholar
• Osby U, Tiainen A, Backlund L, et al. Psychiatric admissions and hospitalization costs in bipolar disorder in Sweden. J Affect Disord 2009;115:315-22
   PubMed Web of Science ®Google Scholar
• Michalak EE, Murray G, CREST.BD. Development of the QoL.BD: a disorder-specific scale to assess quality of life in bipolar disorder. Bipolar Disord 2010;12:727-40
   PubMed Web of Science ®Google Scholar
• Sajatovic M, Jenkins JH, Cassidy KA, et al. Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder. J Affect Disord 2009;115:360-6
   PubMed Web of Science ®Google Scholar
• Zimmerman M, McGlinchey JB, Posternak MA, et al. How should remission from depression be defined? The depressed patient's perspective. Am J Psychiatry 2006;163:148-50
   PubMed Web of Science ®Google Scholar
• Hope ML, Page AC, Hooke GR. The value of adding the Quality of Life Enjoyment and Satisfaction Questionnaire to outcome assessments of psychiatric inpatients with mood and affective disorders. Qual Life Res 2009;18:647-55
   PubMed Web of Science ®Google Scholar
• Michalak EE, Yatham LN, Lam RW. Quality of life in bipolar disorder: a review of the literature. Health Qual Life Outcomes 2005;3:72
   PubMedGoogle Scholar
• Namjoshi MA, Buesching DP. A review of the health-related quality of life literature in bipolar disorder. Qual Life Res 2001;10:105-15
   PubMed Web of Science ®Google Scholar
• Dean BB, Gerner D, Gerner RH. A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin 2004;20:139-54
   PubMed Web of Science ®Google Scholar
• Revicki DA, Matza LS, Flood E, et al. Bipolar disorder and health-related quality of life: review of burden of disease and clinical trials. Pharmacoeconomics 2005;23:583-94
   PubMed Web of Science ®Google Scholar
• Michalak EE, Yatham LN, Kolesar S, et al. Bipolar disorder and quality of life: a patient-centered perspective. Qual Life Res 2006;15:25-37
   PubMed Web of Science ®Google Scholar
• Murray G, Michalak EE. The quality of life construct in bipolar disorder research and practice: past, present, and possible futures. Bipolar Disord 2012;14:793-6
   PubMed Web of Science ®Google Scholar
• Shi L, Namjoshi MA, Zhang F, et al. Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int Clin Psychopharmacol 2002;17:227-37
   PubMed Web of Science ®Google Scholar
• Namjoshi MA, Rajamannar G, Jacobs T, et al. Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania: results from a randomized trial. J Affect Disord 2002;69:109-18
   PubMed Web of Science ®Google Scholar
• Revicki DA, Paramore LC, Sommerville KW, et al. Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. J Clin Psychiatry 2003;64:288-94
   PubMed Web of Science ®Google Scholar
• Saphris (asenapine sublingual tablets). Whitehouse Station, NJ: Schering Corporation, subsidiary of Merck & Co. Inc., 2010
   Google Scholar
• European Medicines Agency: Sycrest (asenapine). Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001177/human_med_001379.jsp&mid=WC0b01ac058001d124 [Last accessed 29 November 2013]
   Google Scholar
• McIntyre RS, Cohen M, Zhao J, et al. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial. J Affect Disord 2010;122:27-38
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Cohen M, Zhao J, et al. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states. Bipolar Disord 2009;11:673-86
   PubMed Web of Science ®Google Scholar
• Azorin JM, Sapin C, Weiller E. Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses. J Affect Disord 2013;145:62-9
   PubMed Web of Science ®Google Scholar
• Maruish M (ed.). User's manual for the SF-36v2 Health Survey, 3rd edn. Lincoln: QualityMetric Inc., 2012
   Google Scholar
• IsHak WW, Brown K, Aye SS, et al. Health-related quality of life in bipolar disorder. Bipolar Disord 2012;14:6-18
   PubMed Web of Science ®Google Scholar
• Michalak EE, Murray G, Young AH, et al. Burden of bipolar depression: impact of disorder and medications on quality of life. CNS Drugs 2008;22:389-406
   PubMed Web of Science ®Google Scholar
• Dikeos D, Badr MG, Yang F, et al. Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics. World J Biol Psychiatry 2010;11:667-76
   PubMed Web of Science ®Google Scholar
• Sapin C, Corson H, Hansen K. The effect of asenapine on health-related quality of life in patients with manic or mixed episodes associated with bipolar I disorder. 2nd International Congress on Neurobiology, Psychopharmacology & Treatment Guidance, Thessaloniki (Greece), 24-27 Nov 2011
   Google Scholar
• Solomon DA, Leon AC, Endicott J, et al. Empirical typology of bipolar I mood episodes. Br J Psychiatry 2009;195:525-30
   PubMed Web of Science ®Google Scholar
• Suppes T, Marangell LB, Bernstein IH, et al. A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. J Affect Disord 2008;111:334-43
   PubMed Web of Science ®Google Scholar
• Sachs G, Sanchez R, Marcus R, et al. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Psychopharmacol 2006;20:536-46
   PubMed Web of Science ®Google Scholar
• Tohen M, Sanger TM, McElroy SL, et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999;156:702-9
   PubMed Web of Science ®Google Scholar
• Tohen M, Jacobs TG, Grundy SL, et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry 2000;57:841-9
   PubMed Web of Science ®Google Scholar
• Zhang H, Wisniewski SR, Bauer MS, et al. Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants. Compr Psychiatry 2006;47:161-8
   PubMed Web of Science ®Google Scholar
• Leidy NK, Palmer C, Murray M, et al. Health-related quality of life assessment in euthymic and depressed patients with bipolar disorder. Psychometric performance of four self-report measures. J Affect Disord 1998;48:207-14
   PubMed Web of Science ®Google Scholar